Kidney Cysts in Hypophosphatemic Rickets With Hypercalciuria: A Case Series.

Case series HHRH SLC34A3 gene hypercalciuria hypophosphatemic rickets with hypercalciuria kidney cyst nephrocalcinosis urinary stone disease

Journal

Kidney medicine
ISSN: 2590-0595
Titre abrégé: Kidney Med
Pays: United States
ID NLM: 101756300

Informations de publication

Date de publication:
Mar 2022
Historique:
entrez: 7 4 2022
pubmed: 8 4 2022
medline: 8 4 2022
Statut: epublish

Résumé

Hereditary hypophosphatemic rickets with hypercalciuria (HHRH) is a rare monogenic disorder caused by Case series. Medical records from the Mayo Clinic and the Rare Kidney Stone Consortium monogenic stone disease database were queried for patients with a genetically confirmed HHRH diagnosis. The number, sizes, and locations of kidney cysts in each patient were recorded. Twelve patients with Retrospective study, possible selection bias, single-center experience. A strong association between HHRH and kidney cysts was observed. Similarities in the biochemical profiles of HHRH and CYP24A1 deficiency suggest elevated active vitamin D and hypercalciuria may be potential cystogenic factors. Further studies are needed to understand how genetic changes in

Identifiants

pubmed: 35386604
doi: 10.1016/j.xkme.2022.100419
pii: S2590-0595(22)00015-2
pmc: PMC8978140
doi:

Types de publication

Journal Article

Langues

eng

Pagination

100419

Subventions

Organisme : NCATS NIH HHS
ID : R21 TR003174
Pays : United States

Informations de copyright

© 2022 The Authors.

Références

Am J Kidney Dis. 2014 May;63(5):713-35
pubmed: 24647050
Kidney Int Rep. 2021 May 12;6(7):1895-1903
pubmed: 34307984
J Endocrinol Invest. 2009 Sep;32(8):690-4
pubmed: 19516087
N Engl J Med. 1987 Jan 15;316(3):125-9
pubmed: 3796683
Am J Kidney Dis. 2012 May;59(5):611-8
pubmed: 22398108
N Engl J Med. 1985 Mar 7;312(10):611-7
pubmed: 2983203
J Clin Endocrinol Metab. 2012 Mar;97(3):E423-7
pubmed: 22337913
Nephrol Dial Transplant. 2016 May;31(5):798-806
pubmed: 26932693
J Am Soc Nephrol. 2014 Oct;25(10):2366-75
pubmed: 24700880
J Clin Invest. 2019 Jul 30;129(10):4506-4522
pubmed: 31361604
Kidney Int Rep. 2019 May 17;4(8):1179-1186
pubmed: 31440709

Auteurs

Christian Hanna (C)

Division of Pediatric Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota.

Theodora A Potretzke (TA)

Division of Radiology, Mayo Clinic, Rochester, Minnesota.

Maroun Chedid (M)

Division of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota.

Laureano J Rangel (LJ)

Department of Quantitative Health Research, Mayo Clinic, Rochester, Minnesota.

Jennifer Arroyo (J)

Division of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota.

Dalia Zubidat (D)

Division of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota.

Peter J Tebben (PJ)

Division of Endocrinology, Mayo Clinic, Rochester, Minnesota.

Andrea G Cogal (AG)

Division of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota.

Vicente E Torres (VE)

Division of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota.

Peter C Harris (PC)

Division of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota.

David J Sas (DJ)

Division of Pediatric Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota.

John C Lieske (JC)

Division of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota.
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota.

Dawn S Milliner (DS)

Division of Pediatric Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota.
Division of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota.

Fouad T Chebib (FT)

Division of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota.

Classifications MeSH